EP3222724

SILENCE THERAPEUTICS
Application Number
EP17160954A
Filing Date
Aug 5, 2003
Status
Granted And Under Opposition
Sep 28, 2018
Grant Date
Oct 31, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3222724B1 was granted on Oct 31, 2018 by Silence Therapeutics The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALNYLAM PHARMACEUTICALSOct 31, 2018WITHDRAWN

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.